{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:08:39Z","timestamp":1793210919256,"version":"4.5.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Washington University in Saint Louis"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1053\/j.ajkd.2019.07.012","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:07:49Z","timestamp":1570666069000},"page":"497-507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":131,"title":["Proton Pump Inhibitors and the Kidney: Implications of Current Evidence for Clinical Practice and When and How to Deprescribe"],"prefix":"10.1053","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2600-0434","authenticated-orcid":false,"given":"Ziyad","family":"Al-Aly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetha","family":"Maddukuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1053\/j.ajkd.2019.07.012_bib1","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999-2012","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2019.07.012_bib2","unstructured":"CHPA. OTC Sales by Category 2014-2017. https:\/\/www.chpa.org\/OTCsCategory.aspx. Accessed March 2, 2019."},{"issue":"9","key":"10.1053\/j.ajkd.2019.07.012_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203878","article-title":"Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients","volume":"13","author":"Lee","year":"2018","journal-title":"PloS One"},{"issue":"7634","key":"10.1053\/j.ajkd.2019.07.012_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/bmj.39406.449456.BE","article-title":"Overprescribing proton pump inhibitors","volume":"336","author":"Forgacs","year":"2008","journal-title":"BMJ"},{"issue":"6","key":"10.1053\/j.ajkd.2019.07.012_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/qjmed\/hcn035","article-title":"Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease","volume":"101","author":"Choudhry","year":"2008","journal-title":"QJM"},{"issue":"10","key":"10.1053\/j.ajkd.2019.07.012_bib6","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1365-2036.2005.02454.x","article-title":"Long-term use of acid suppression started inappropriately during hospitalization","volume":"21","author":"Zink","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1053\/j.ajkd.2019.07.012_bib7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/ndt\/18.3.570","article-title":"Overuse of acid suppressant drugs in patients with chronic renal failure","volume":"18","author":"Strid","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"24","key":"10.1053\/j.ajkd.2019.07.012_bib8","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1001\/jama.2008.892","article-title":"Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States","volume":"300","author":"Qato","year":"2008","journal-title":"JAMA"},{"issue":"10","key":"10.1053\/j.ajkd.2019.07.012_bib9","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1681\/ASN.2015121377","article-title":"Proton pump inhibitors and risk of incident CKD and progression to ESRD","volume":"27","author":"Xie","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2019.07.012_bib10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/archinternmed.2010.64","article-title":"Failing the acid test: benefits of proton pump inhibitors may not justify the risks for many users","volume":"170","author":"Katz","year":"2010","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1053\/j.ajkd.2019.07.012_bib11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamainternmed.2013.4068","article-title":"Reversing gears: discontinuing medication therapy to prevent adverse events","volume":"173","author":"Linsky","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"9","key":"10.1053\/j.ajkd.2019.07.012_bib12","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/archinternmed.2010.90","article-title":"Less is more: how less health care can result in better health","volume":"170","author":"Grady","year":"2010","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1053\/j.ajkd.2019.07.012_bib13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamainternmed.2015.7927","article-title":"Adverse effects associated with proton pump inhibitors","volume":"176","author":"Schoenfeld","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1053\/j.ajkd.2019.07.012_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015735","article-title":"Risk of death among users of proton pump inhibitors: a longitudinal observational cohort study of United States veterans","volume":"7","author":"Xie","year":"2017","journal-title":"BMJ Open"},{"issue":"3","key":"10.1053\/j.ajkd.2019.07.012_bib15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MNH.0000000000000406","article-title":"The association of proton pump inhibitors and chronic kidney disease: cause or confounding?","volume":"27","author":"Li","year":"2018","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"10.1053\/j.ajkd.2019.07.012_bib16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","article-title":"Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis","volume":"73","author":"Gomm","year":"2016","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1053\/j.ajkd.2019.07.012_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/gutjnl-2017-314605","article-title":"Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study","volume":"67","author":"Cheung","year":"2018","journal-title":"Gut"},{"issue":"4","key":"10.1053\/j.ajkd.2019.07.012_bib18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1586\/17512433.2013.811206","article-title":"Perils and pitfalls of long-term effects of proton pump inhibitors","volume":"6","author":"Wilhelm","year":"2013","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1053\/j.ajkd.2019.07.012_bib19","article-title":"Proton pump inhibitors and risk of gastric cancer in a case-control study","author":"Lai","year":"2018","journal-title":"Gut"},{"key":"10.1053\/j.ajkd.2019.07.012_bib20","article-title":"Proton pump inhibitors and the risk for gastric cancer: possible confounding by serum vitamin B 12","author":"Gueta","year":"2017","journal-title":"Gut"},{"key":"10.1053\/j.ajkd.2019.07.012_bib21","article-title":"Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD","author":"Peng","year":"2018","journal-title":"Gut"},{"key":"10.1053\/j.ajkd.2019.07.012_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2017-315729","article-title":"Proton-pump inhibitors and increased gastric cancer risk: time-related biases","author":"Suissa","year":"2018","journal-title":"Gut"},{"key":"10.1053\/j.ajkd.2019.07.012_bib23","article-title":"Helicobacter pylori eradication failure may have confounded the recent large-scale health database study that showed proton pump inhibitors increase gastric cancer risk","author":"Suzuki","year":"2017","journal-title":"Gut"},{"key":"10.1053\/j.ajkd.2019.07.012_bib24","article-title":"Long-term proton pump inhibitors use and risk of gastric cancer: a meta-analysis of 926 386 participants","author":"Wan","year":"2018","journal-title":"Gut"},{"issue":"10","key":"10.1053\/j.ajkd.2019.07.012_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017739","article-title":"Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden","volume":"7","author":"Brusselaers","year":"2017","journal-title":"BMJ Open"},{"issue":"9","key":"10.1053\/j.ajkd.2019.07.012_bib26","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/sj.bjc.6605024","article-title":"Proton pump inhibitors and risk of gastric cancer: a population-based cohort study","volume":"100","author":"Poulsen","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1053\/j.ajkd.2019.07.012_bib27","doi-asserted-by":"crossref","first-page":"l1580","DOI":"10.1136\/bmj.l1580","article-title":"Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study","volume":"365","author":"Xie","year":"2019","journal-title":"BMJ"},{"issue":"2","key":"10.1053\/j.ajkd.2019.07.012_bib28","doi-asserted-by":"crossref","first-page":"E166","DOI":"10.9778\/cmajo.20140074","article-title":"Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study","volume":"3","author":"Antoniou","year":"2015","journal-title":"CMAJ Open"},{"key":"10.1053\/j.ajkd.2019.07.012_bib29","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2369-14-150","article-title":"Proton pump inhibitors and acute kidney injury: a nested case-control study","volume":"14","author":"Klepser","year":"2013","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2019.07.012_bib30","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/ki.2014.74","article-title":"A\u00a0nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use","volume":"86","author":"Blank","year":"2014","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ajkd.2019.07.012_bib31","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/ki.2010.89","article-title":"Acute interstitial nephritis","volume":"77","author":"Praga","year":"2010","journal-title":"Kidney Int"},{"issue":"8","key":"10.1053\/j.ajkd.2019.07.012_bib32","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrneph.2010.71","article-title":"Drug-induced acute interstitial nephritis","volume":"6","author":"Perazella","year":"2010","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2019.07.012_bib33","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2125.2007.02927.x","article-title":"Proton pump inhibitor-induced acute interstitial nephritis","volume":"64","author":"Harmark","year":"2007","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1053\/j.ajkd.2019.07.012_bib34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5414\/CNP68065","article-title":"Proton pump inhibitors and the kidney: critical review","volume":"68","author":"Brewster","year":"2007","journal-title":"Clin Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2019.07.012_bib35","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7326\/0003-4819-151-10-200911170-00016","article-title":"Hypomagnesemia induced by several proton-pump inhibitors","volume":"151","author":"Broeren","year":"2009","journal-title":"Ann Intern Med"},{"issue":"15","key":"10.1053\/j.ajkd.2019.07.012_bib36","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1001\/archinternmed.2011.199","article-title":"Hypomagnesemia and proton pump inhibitors: below the tip of the iceberg","volume":"171","author":"Furlanetto","year":"2011","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1053\/j.ajkd.2019.07.012_bib37","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1053\/j.ajkd.2015.05.012","article-title":"Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study","volume":"66","author":"Kieboom","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1053\/j.ajkd.2019.07.012_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112558","article-title":"The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis","volume":"9","author":"Park","year":"2014","journal-title":"PloS One"},{"issue":"4","key":"10.1053\/j.ajkd.2019.07.012_bib39","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/ki.2012.462","article-title":"Proton pump inhibitors and hypomagnesemia: a rare but serious complication","volume":"83","author":"Perazella","year":"2013","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ajkd.2019.07.012_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001736","article-title":"Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study","volume":"11","author":"Zipursky","year":"2014","journal-title":"PLoS Med"},{"issue":"6","key":"10.1053\/j.ajkd.2019.07.012_bib41","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.kint.2016.12.021","article-title":"Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury","volume":"91","author":"Xie","year":"2017","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ajkd.2019.07.012_bib42","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.4412","article-title":"Changes in the US burden of chronic kidney disease from 2002 to 2016: an analysis of the Global Burden of Disease study","volume":"1","author":"Bowe","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1053\/j.ajkd.2019.07.012_bib43","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.kint.2018.04.011","article-title":"Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016","volume":"94","author":"Xie","year":"2018","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2019.07.012_bib44","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.kint.2017.08.033","article-title":"Higher blood urea nitrogen is associated with increased risk of incident diabetes mellitus","volume":"93","author":"Xie","year":"2018","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ajkd.2019.07.012_bib45","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.2215\/CJN.04480415","article-title":"Rate of kidney function decline and risk of hospitalizations in stage 3A CKD","volume":"10","author":"Xie","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2019.07.012_bib46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.ajkd.2016.02.039","article-title":"Estimated GFR trajectories of people entering CKD stage 4 and subsequent kidney disease outcomes and mortality","volume":"68","author":"Xie","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1053\/j.ajkd.2019.07.012_bib47","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/ki.2012.276","article-title":"Greater variability in kidney function is associated with an increased risk of death","volume":"82","author":"Al-Aly","year":"2012","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2019.07.012_bib48","doi-asserted-by":"crossref","first-page":"a425","DOI":"10.1136\/bmj.39505.738981.BE","article-title":"Omeprazole and refractory hypomagnesaemia [abstract]","volume":"337","author":"Shabajee","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1053\/j.ajkd.2019.07.012_bib49","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/ki.2012.452","article-title":"Proton-pump inhibitor use is associated with low serum magnesium concentrations","volume":"83","author":"Danziger","year":"2013","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2019.07.012_bib50","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/0003-4819-155-6-201109200-00022","article-title":"Recurrent hypomagnesemia with proton-pump inhibitor rechallenge","volume":"155","author":"Quasdorff","year":"2011","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1053\/j.ajkd.2019.07.012_bib51","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/jcph.316","article-title":"The association of proton pump inhibitors and hypomagnesemia in the community setting","volume":"54","author":"Markovits","year":"2014","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"4","key":"10.1053\/j.ajkd.2019.07.012_bib52","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1053\/j.ajkd.2013.02.373","article-title":"Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study","volume":"62","author":"Koulouridis","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2019.07.012_bib53","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.ajkd.2009.11.019","article-title":"A\u00a0case series of proton pump inhibitor-induced hypomagnesemia","volume":"56","author":"Hoorn","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1053\/j.ajkd.2019.07.012_bib54","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.mayocp.2018.07.006","article-title":"A\u00a0relationship between proton pump inhibitors and hypomagnesemia?","volume":"93","author":"Famularo","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"10.1053\/j.ajkd.2019.07.012_bib55","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/ijcp.12469","article-title":"Impact of proton pump inhibitor use on magnesium homoeostasis: a cross-sectional study in a tertiary emergency department","volume":"68","author":"Lindner","year":"2014","journal-title":"Int J Clin Pract"},{"issue":"3","key":"10.1053\/j.ajkd.2019.07.012_bib56","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000360011","article-title":"Hypomagnesemia in hemodialysis patients: role of\u00a0proton pump inhibitors","volume":"39","author":"Alhosaini","year":"2014","journal-title":"Am J Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2019.07.012_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143656","article-title":"Proton pump inhibitor use and magnesium concentrations in hemodialysis patients: a cross-sectional study","volume":"10","author":"Nakashima","year":"2015","journal-title":"PloS One"},{"issue":"6","key":"10.1053\/j.ajkd.2019.07.012_bib58","first-page":"707","article-title":"Proton-pump inhibitors do not influence serum magnesium levels in renal transplant recipients","volume":"27","author":"Van Ende","year":"2014","journal-title":"J\u00a0Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2019.07.012_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197400","article-title":"Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease","volume":"13","author":"Hughes","year":"2018","journal-title":"PloS One"},{"key":"10.1053\/j.ajkd.2019.07.012_bib60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejim.2016.01.026","article-title":"Is there a relationship between hypomagnesemia and proton-pump inhibitors in patients on chronic hemodialysis?","volume":"30","author":"Mikolasevic","year":"2016","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1053\/j.ajkd.2019.07.012_bib61","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/0004563215569423","article-title":"The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis","volume":"52","author":"Cegla","year":"2015","journal-title":"Ann Clin Biochem"},{"issue":"7","key":"10.1053\/j.ajkd.2019.07.012_bib62","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3109\/0886022X.2015.1057800","article-title":"Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies","volume":"37","author":"Cheungpasitporn","year":"2015","journal-title":"Ren Fail"},{"issue":"13","key":"10.1053\/j.ajkd.2019.07.012_bib63","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015011","article-title":"Does the use of proton pump inhibitors\u00a0increase the risk of hypomagnesemia: an updated systematic review and meta-analysis","volume":"98","author":"Liao","year":"2019","journal-title":"Medicine"},{"key":"10.1053\/j.ajkd.2019.07.012_bib64","unstructured":"US Food and Drug Administration. FDA drug safety communication: low magnesium levels can be associated with long-term use of proton pump inhibitor drugs (PPIs). https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-low-magnesium-levels-can-be-associated-long-term-use-proton-pump. Accessed March 2, 2019."},{"issue":"4","key":"10.1053\/j.ajkd.2019.07.012_bib65","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/0002-9343(92)90181-A","article-title":"Acute interstitial nephritis due to omeprazole","volume":"93","author":"Ruffenach","year":"1992","journal-title":"Am J Med"},{"issue":"6","key":"10.1053\/j.ajkd.2019.07.012_bib66","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/ndt\/gfh137","article-title":"Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors: experience from a single UK renal unit","volume":"19","author":"Torpey","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2019.07.012_bib67","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/phar.2235","article-title":"Proton pump inhibitors and risk of acute and chronic kidney disease: a retrospective cohort study","volume":"39","author":"Hart","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1053\/j.ajkd.2019.07.012_bib68","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.14157","article-title":"Acid-suppressive drugs and risk of kidney disease: a systematic review and meta-analysis","author":"Qiu","year":"2018","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"2","key":"10.1053\/j.ajkd.2019.07.012_bib69","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/ndt\/gfw470","article-title":"The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis","volume":"33","author":"Nochaiwong","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2019.07.012_bib70","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/pds.3329","article-title":"Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury","volume":"21","author":"Leonard","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"10.1053\/j.ajkd.2019.07.012_bib71","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","article-title":"Proton pump inhibitor use and the risk of chronic kidney disease","volume":"176","author":"Lazarus","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"15","key":"10.1053\/j.ajkd.2019.07.012_bib72","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003363","article-title":"Association between the use of proton pump inhibitors and the risk of ESRD in renal diseases: a population-based, case-control study","volume":"95","author":"Peng","year":"2016","journal-title":"Medicine"},{"issue":"1","key":"10.1053\/j.ajkd.2019.07.012_bib73","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12882-016-0325-4","article-title":"Proton pump inhibitors are associated with increased risk of development of chronic kidney disease","volume":"17","author":"Arora","year":"2016","journal-title":"BMC Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2019.07.012_bib74","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1007\/s10620-017-4725-5","article-title":"Associations of proton-pump inhibitors and H2 receptor antagonists with chronic kidney disease: a meta-analysis","volume":"62","author":"Wijarnpreecha","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1053\/j.ajkd.2019.07.012_bib75","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1053\/j.gastro.2017.05.046","article-title":"Association between proton pump inhibitor use and risk of progression of chronic kidney disease","volume":"153","author":"Klatte","year":"2017","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1053\/j.ajkd.2019.07.012_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204231","article-title":"Duration and dosing of proton pump inhibitors associated with high incidence of chronic kidney disease in population-based cohort","volume":"13","author":"Rodriguez-Poncelas","year":"2018","journal-title":"PloS One"},{"key":"10.1053\/j.ajkd.2019.07.012_bib77","article-title":"Using proton pump inhibitors correlates with an increased risk of chronic kidney disease: a nationwide database-derived case-controlled study","author":"Hung","year":"2017","journal-title":"Fam Pract"},{"issue":"2","key":"10.1053\/j.ajkd.2019.07.012_bib78","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ekir.2017.11.001","article-title":"Proton pump inhibitor usage and the risk of mortality in hemodialysis patients","volume":"3","author":"de Francisco","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"5","key":"10.1053\/j.ajkd.2019.07.012_bib79","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJMra1614394","article-title":"Evidence for health decision making - beyond randomized, controlled trials","volume":"377","author":"Frieden","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1053\/j.ajkd.2019.07.012_bib80","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/archinte.166.9.965","article-title":"Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach","volume":"166","author":"Kaltenbach","year":"2006","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1053\/j.ajkd.2019.07.012_bib81","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.kint.2017.05.010","article-title":"The authors reply [letter]","volume":"92","author":"Xie","year":"2017","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2019.07.012_bib82","first-page":"281","article-title":"The precautionary principle and medical decision making","volume":"29","author":"Resnik","year":"2004","journal-title":"J\u00a0Med Philos"},{"issue":"2","key":"10.1053\/j.ajkd.2019.07.012_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/pharmacy6020043","article-title":"Comprehension of top 200 prescribed drugs in the US as a resource for pharmacy teaching, training and practice","volume":"6","author":"Fuentes","year":"2018","journal-title":"Pharmacy"},{"key":"10.1053\/j.ajkd.2019.07.012_bib84","series-title":"Heartburn drugs may increase risk of early death","author":"Bakalar","year":"2017"},{"key":"10.1053\/j.ajkd.2019.07.012_bib85","series-title":"People taking heartburn drugs could have higher risk of\u00a0death, study claims","author":"Rudd","year":"2017"},{"key":"10.1053\/j.ajkd.2019.07.012_bib86","series-title":"Heartburn drugs tied to increased risk of early death, study says","author":"Scutti","year":"2017"},{"key":"10.1053\/j.ajkd.2019.07.012_bib87","series-title":"Popular medications linked to higher risk of kidney failure","author":"Christensen","year":"2016"},{"key":"10.1053\/j.ajkd.2019.07.012_bib88","series-title":"Commonly used heartburn drugs may lead to kidney damage: study","author":"Welch","year":"2016"},{"key":"10.1053\/j.ajkd.2019.07.012_bib89","series-title":"Some heartburn drugs linked with higher risk of death","author":"Marcus","year":"2017"},{"key":"10.1053\/j.ajkd.2019.07.012_bib90","series-title":"Warning over kidney risk from heartburn drugs","author":"BBC","year":"2016"},{"key":"10.1053\/j.ajkd.2019.07.012_bib91","article-title":"Heartburn and kidney disease","author":"Spry","year":"2017","journal-title":"Huffington Post"},{"key":"10.1053\/j.ajkd.2019.07.012_bib92","series-title":"Heartburn meds associated with increased risk of kidney damage, study finds","year":"2017"},{"key":"10.1053\/j.ajkd.2019.07.012_bib93","series-title":"Heartburn drugs taken by millions may increase risk of early death, study suggests","year":"2017"},{"issue":"2","key":"10.1053\/j.ajkd.2019.07.012_bib94","doi-asserted-by":"crossref","first-page":"244","DOI":"10.14309\/ajg.0000000000000061","article-title":"Patients' perceptions of proton pump inhibitor risks and attempts at discontinuation: a national survey","volume":"114","author":"Kurlander","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1053\/j.ajkd.2019.07.012_bib95","first-page":"291","article-title":"Deprescribing proton pump inhibitors","volume":"71","author":"Zed","year":"2018","journal-title":"Can J Hosp Pharm"},{"issue":"3","key":"10.1053\/j.ajkd.2019.07.012_bib96","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4212\/cjhp.v66i3.1261","article-title":"Deprescribing: what is it and what does the evidence tell us?","volume":"66","author":"Thompson","year":"2013","journal-title":"Can J Hosp Pharm"},{"issue":"6","key":"10.1053\/j.ajkd.2019.07.012_bib97","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/fampra\/cmu050","article-title":"Strategies for discontinuation of proton pump inhibitors: a systematic review","volume":"31","author":"Jarb\u00f8l","year":"2014","journal-title":"Fam Pract"},{"issue":"3","key":"10.1053\/j.ajkd.2019.07.012_bib98","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/jamainternmed.2016.8254","article-title":"Clinicians' expectations of the benefits and harms of treatments, screening, and tests: a systematic review","volume":"177","author":"Hoffmann","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1053\/j.ajkd.2019.07.012_bib99","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2017.3628","article-title":"Don't just do something, stand there!","author":"Sinha","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1053\/j.ajkd.2019.07.012_bib100","doi-asserted-by":"crossref","first-page":"l666","DOI":"10.1136\/bmj.l666","article-title":"Helen Salisbury: the perils of deprescribing","volume":"364","author":"Salisbury","year":"2019","journal-title":"BMJ"},{"issue":"18","key":"10.1053\/j.ajkd.2019.07.012_bib101","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/jama.2018.16473","article-title":"Overcoming inertia to improve medication use and deprescribing","volume":"320","author":"Steinman","year":"2018","journal-title":"JAMA"},{"issue":"9","key":"10.1053\/j.ajkd.2019.07.012_bib102","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/2042098618781524","article-title":"Shed-MEDS: pilot\u00a0of a patient-centered deprescribing framework reduces medications in hospitalized older adults being transferred to inpatient postacute care","volume":"9","author":"Petersen","year":"2018","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"10.1053\/j.ajkd.2019.07.012_bib103","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12877-018-0978-x","article-title":"The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people","volume":"18","author":"Todd","year":"2018","journal-title":"BMC Geriatr"},{"issue":"5","key":"10.1053\/j.ajkd.2019.07.012_bib104","first-page":"354","article-title":"Deprescribing proton pump inhibitors: evidence-based clinical practice guideline","volume":"63","author":"Farrell","year":"2017","journal-title":"Can Fam Physician"},{"key":"10.1053\/j.ajkd.2019.07.012_bib105","first-page":"CD011969","article-title":"Deprescribing versus continuation of chronic proton pump inhibitor use in\u00a0adults","volume":"3","author":"Boghossian","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.ajkd.2019.07.012_bib106","unstructured":"ClinicalTrials.gov. Evaluation of the National Randomized Proton\u00a0Pump Inhibitor De-prescribing (RaPPID) Program (RaPPID)."},{"issue":"18","key":"10.1053\/j.ajkd.2019.07.012_bib107","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.16131","article-title":"Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial","volume":"320","author":"Martin","year":"2018","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2019.07.012_bib108","unstructured":"Choosing Wisely Canada. Bye-bye, PPI. A tookit for deprescribing proton pump inhibitors in EMR-enabled primary care settings\u00a02017."},{"issue":"2","key":"10.1053\/j.ajkd.2019.07.012_bib109","first-page":"164","article-title":"Deprescribing in a family health team: a study of chronic proton pump\u00a0inhibitor use","volume":"8","author":"Walsh","year":"2016","journal-title":"J\u00a0Primary Health Care"},{"issue":"1","key":"10.1053\/j.ajkd.2019.07.012_bib110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/1715163518816719","article-title":"Continuation or deprescribing of proton pump inhibitors: a consult patient decision aid","volume":"152","author":"Thompson","year":"2019","journal-title":"Can Pharm J"},{"issue":"10","key":"10.1053\/j.ajkd.2019.07.012_bib111","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5694\/mja18.00674","article-title":"Deprescribing proton pump inhibitors: why, when and how","volume":"209","author":"Bytzer","year":"2018","journal-title":"Med J Aust"},{"issue":"1","key":"10.1053\/j.ajkd.2019.07.012_bib112","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/1060028014558290","article-title":"Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors","volume":"49","author":"Reeve","year":"2015","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1053\/j.ajkd.2019.07.012_bib113","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/jcpt.12613","article-title":"We have had a gutful: the need for deprescribing proton pump inhibitors","volume":"43","author":"Naunton","year":"2018","journal-title":"J\u00a0Clin Pharm Ther"},{"issue":"6","key":"10.1053\/j.ajkd.2019.07.012_bib114","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/qjmed\/hcq021","article-title":"Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series","volume":"103","author":"Mackay","year":"2010","journal-title":"QJM"},{"issue":"7","key":"10.1053\/j.ajkd.2019.07.012_bib115","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.endonu.2011.11.011","article-title":"[Severe hypomagnesemia refractory to oral supplementation associated to omeprazole treatment]","volume":"59","author":"Martinez Faedo","year":"2012","journal-title":"Endocrinol Nutr"},{"key":"10.1053\/j.ajkd.2019.07.012_bib116","unstructured":"Frieden T. Why the \u2018gold standard\u2019 of medical research is no longer enough. 2017. Accessed March 2, 2019."}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638619309394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638619309394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:27:11Z","timestamp":1759462031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638619309394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":116,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0272638619309394"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2019.07.012","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton Pump Inhibitors and the Kidney: Implications of Current Evidence for Clinical Practice and When and How to Deprescribe","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2019.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. This is a US Government Work. There are no restrictions on its use.","name":"copyright","label":"Copyright"}]}}